Trials / Not Yet Recruiting
Not Yet RecruitingNCT06042335
A Feasibility Study for the DAISe EZ Thrombectomy Device - Pacific
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- MIVI Neuroscience, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a prospective, multi-center, single arm, feasibility study that will enroll a maximum of 20 subjects. A maximum of 5 investigational centers in Australia will participate. Enrollment is expected to take about 4 months, subject participation will last about 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DAISe EZ | DAISe Thrombectomy System for mechanical thrombectomy |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2023-09-18
- Last updated
- 2024-08-09
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06042335. Inclusion in this directory is not an endorsement.